Jorge Ronco

Title: **Innovative Contributions of Jorge Ronco in Cutaneous Immunisation**

Introduction

Jorge Ronco, a distinguished inventor based in Rambouillet, France, has made significant strides in the field of immunology. With two registered patents to his name, Ronco’s innovations focus on enhancing vaccine delivery systems to improve immune responses in mammals, particularly humans. His work has the potential to transform the way vaccines are administered and how immune responses are elicited.

Latest Patents

Ronco’s most recent patents reflect his commitment to advancing vaccination methods. The first patent, titled "Method and compositions for cutaneous immunisation," addresses the development of a system that delivers vaccines through the cutaneous route. This invention encompasses the use of a unique device featuring a condensation compartment designed for epicutaneous vaccination. Notably, it introduces protocols that enable an efficient immune response without necessitating any skin treatment. This innovation can be deployed in various mammals, primarily aimed at inducing both therapeutic and preventive immune responses against various antigens.

The second patent, known as "Patches and uses thereof," elaborates on a patch equipped with electrostatic properties. This patch is innovatively designed with a periphery coated with an adhesive material, while the non-adhesive surface is covered with at least one biologically active substance in particle form. The particles adhere to the non-adhesive part of the support through electrostatic forces, presenting a novel approach to vaccine delivery.

Career Highlights

Jorge Ronco currently holds a position at DBV Technologies, where he continues to develop groundbreaking solutions in immunisation technologies. His role at the company exemplifies his dedication to advancing the field of vaccines and enhancing public health through innovative research.

Collaborations

Ronco collaborates with esteemed colleagues such as Bertrand Dupont and Christophe Dupont, whose combined efforts contribute to the successful development and implementation of his patented technologies. This collaboration is instrumental in pushing the boundaries of what is currently achievable in the realm of cutaneous immunisation.

Conclusion

Through his remarkable patents and active role at DBV Technologies, Jorge Ronco exemplifies the spirit of innovation in the health sector. His work on enhancing vaccine delivery systems could play a crucial role in the future of immunisation, marking a significant advancement in medical science. As innovations like those of Ronco continue to unfold, they hold the promise of improved health outcomes for individuals worldwide.